<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30135317</article-id>
<article-id pub-id-type="pmc">6141175</article-id>
<article-id pub-id-type="publisher-id">122156</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.122156</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Oral nitrite restores age-dependent phenotypes in eNOS-null mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tenopoulou</surname>
<given-names>Margarita</given-names>
</name>
<email>tenopoulou@email.chop.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doulias</surname>
<given-names>Paschalis-Thomas</given-names>
</name>
<email>DOULIAS@email.chop.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakamoto</surname>
<given-names>Kent</given-names>
</name>
<email>nakamoto.22.kent@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berrios</surname>
<given-names>Kiara</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zura</surname>
<given-names>Gabriella</given-names>
</name>
<email>zurag@email.chop.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Chenxi</given-names>
</name>
<email>chenxi.lilyli@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faust</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yakovishina</surname>
<given-names>Veronika</given-names>
</name>
<email>veronikayakovishina@yahoo.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evans</surname>
<given-names>Perry</given-names>
</name>
<email>samesense@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Lu</given-names>
</name>
<email>TANL@EMAIL.CHOP.EDU</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennett</surname>
<given-names>Michael J.</given-names>
</name>
<email>bennettmi@email.chop.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snyder</surname>
<given-names>Nathaniel W.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quinn</surname>
<given-names>William J.</given-names>
<suffix>III</suffix>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baur</surname>
<given-names>Joseph A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Atochin</surname>
<given-names>Dmitriy N.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Paul L.</given-names>
</name>
<email>huangp@helix.mgh.harvard.edu</email>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ischiropoulos</surname>
<given-names>Harry</given-names>
</name>
<email>ischirop@pennmedicine.upenn.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Children’s Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A2"><label>2</label>A.J. Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A3"><label>3</label>Department of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</aff>
<aff id="A4"><label>4</label>Cardiovascular Research Center Massachusetts General Hospital, Boston, Massachusetts, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Harry Ischiropoulos, Children’s Hospital of Philadelphia Research Institute, 417 Abramson Research Center, 3517 Civic Center Boulevard, Philadelphia, Pennsylvania, 19104-4318, USA. Phone: 215.590.5320; Email: <email>ischirop@pennmedicine.upenn.edu</email>.</corresp>
<fn>
<p><bold>Authorship note:</bold> MT and PTD contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2018-08-23T09:00:00-0400" publication-format="electronic">
<day>23</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2018-08-23T09:00:00-0400" publication-format="electronic">
<day>23</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>8</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>3</volume>
<issue>16</issue>
<elocation-id>e122156</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/122156">This article is available online at https://insight.jci.org/articles/view/122156</self-uri>
<abstract>
<p>Alterations in the synthesis and bioavailability of NO are central to the pathogenesis of cardiovascular and metabolic disorders. Although endothelial NO synthase–derived (eNOS-derived) NO affects mitochondrial long-chain fatty acid β-oxidation, the pathophysiological significance of this regulation remains unclear. Accordingly, we determined the contributions of eNOS/NO signaling in the adaptive metabolic responses to fasting and in age-induced metabolic dysfunction. Four-month-old eNOS<sup>–/–</sup> mice are glucose intolerant and exhibit serum dyslipidemia and decreased capacity to oxidize fatty acids. However, during fasting, eNOS<sup>–/–</sup> mice redirect acetyl-CoA to ketogenesis to elevate circulating levels of β-hydroxybutyrate similar to wild-type mice. Treatment of 4-month-old eNOS<sup>–/–</sup> mice with nitrite for 10 days corrected the hypertension and serum hyperlipidemia and normalized the rate of fatty acid oxidation. Fourteen-month-old eNOS<sup>–/–</sup> mice exhibited metabolic derangements, resulting in reduced utilization of fat to generate energy, lower resting metabolic activity, and diminished physical activity. Seven-month administration of nitrite to eNOS<sup>–/–</sup> mice reversed the age-dependent metabolic derangements and restored physical activity. While the eNOS/NO signaling is not essential for the metabolic adaptation to fasting, it is critical for regulating systemic metabolic homeostasis in aging. The development of age-dependent metabolic disorder is prevented by low-dose replenishment of bioactive NO.</p>
</abstract>
<abstract abstract-type="toc">
<p>Age-dependent metabolic derangement and phenotypic decline in eNOS<sup>–/–</sup> mice are reversed by chronic administration of nitrite.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Metabolism</kwd>
<kwd>Therapeutics</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Fatty acid oxidation</kwd>
<kwd>Nitric oxide</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Institutes of Health</institution>
<institution-id>https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>HL054926</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>